JPS55153713A - Pharmaceutical preparation of ribosome containing active substance - Google Patents

Pharmaceutical preparation of ribosome containing active substance

Info

Publication number
JPS55153713A
JPS55153713A JP5428379A JP5428379A JPS55153713A JP S55153713 A JPS55153713 A JP S55153713A JP 5428379 A JP5428379 A JP 5428379A JP 5428379 A JP5428379 A JP 5428379A JP S55153713 A JPS55153713 A JP S55153713A
Authority
JP
Japan
Prior art keywords
active substance
ribosome
wall membrane
pharmaceutical preparation
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5428379A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0240644B2 (fr
Inventor
Takatoshi Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP5428379A priority Critical patent/JPS55153713A/ja
Priority to CA000351077A priority patent/CA1143656A/fr
Priority to DE19803016976 priority patent/DE3016976A1/de
Priority to GB8014793A priority patent/GB2050287B/en
Priority to FR8009985A priority patent/FR2455458A1/fr
Publication of JPS55153713A publication Critical patent/JPS55153713A/ja
Publication of JPH0240644B2 publication Critical patent/JPH0240644B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP5428379A 1979-05-02 1979-05-02 Pharmaceutical preparation of ribosome containing active substance Granted JPS55153713A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP5428379A JPS55153713A (en) 1979-05-02 1979-05-02 Pharmaceutical preparation of ribosome containing active substance
CA000351077A CA1143656A (fr) 1979-05-02 1980-05-01 Substance active incluse dans un lipsome
DE19803016976 DE3016976A1 (de) 1979-05-02 1980-05-02 Liposom mit einem gehalt an einer aktiven substanz und verfahren zu dessen herstellung
GB8014793A GB2050287B (en) 1979-05-02 1980-05-02 Liposomes containing physiologically active substances
FR8009985A FR2455458A1 (fr) 1979-05-02 1980-05-05 Liposomes contenant une substance active, notamment un principe actif de medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5428379A JPS55153713A (en) 1979-05-02 1979-05-02 Pharmaceutical preparation of ribosome containing active substance

Publications (2)

Publication Number Publication Date
JPS55153713A true JPS55153713A (en) 1980-11-29
JPH0240644B2 JPH0240644B2 (fr) 1990-09-12

Family

ID=12966226

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5428379A Granted JPS55153713A (en) 1979-05-02 1979-05-02 Pharmaceutical preparation of ribosome containing active substance

Country Status (5)

Country Link
JP (1) JPS55153713A (fr)
CA (1) CA1143656A (fr)
DE (1) DE3016976A1 (fr)
FR (1) FR2455458A1 (fr)
GB (1) GB2050287B (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60152410A (ja) * 1984-01-23 1985-08-10 Pola Chem Ind Inc 皮膚外用剤
JPS60243022A (ja) * 1984-04-09 1985-12-03 サンド・アクチエンゲゼルシヤフト インタ−リユ−キン療法に関する改良
JPS61100518A (ja) * 1984-10-22 1986-05-19 Ono Pharmaceut Co Ltd ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤
WO2005053643A1 (fr) * 2003-12-01 2005-06-16 Mitsubishi Pharma Corporation Liposome
JP2015514683A (ja) * 2012-02-16 2015-05-21 ブライトサイド イノベーションズ，インコーポレイティド 食品性栄養組成物および使用方法
JP2017066059A (ja) * 2015-09-28 2017-04-06 小林製薬株式会社 リポソーム

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692433A (en) * 1983-10-12 1987-09-08 The Regents Of The University Of California Method and composition for regulating serum calcium levels of mammals
GB8428222D0 (en) * 1984-11-08 1984-12-19 Bentall R H C Quantifying interaction of induced currents
US5023087A (en) * 1986-02-10 1991-06-11 Liposome Technology, Inc. Efficient method for preparation of prolonged release liposome-based drug delivery system
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
DE3852409T2 (de) * 1987-01-27 1995-04-20 Vestar Inc Aus Phospholipiden bestehende Darreichungsform für wasserunlösliche Wirksubstanzen.
US5723147A (en) * 1987-02-23 1998-03-03 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
WO1988009170A1 (fr) * 1987-05-22 1988-12-01 The Liposome Company, Inc. Formulations de lipides du type prostaglandine
US5811118A (en) * 1987-05-22 1998-09-22 The Liposome Company, Inc. Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
SE457933B (sv) * 1987-07-06 1989-02-13 Larsson Kare Farmaceutisk komposition innefattande en vattendispergerad blandning av lipider, monoglycerider och fosfatidylkolin samt dess anvaendning foer framstaellning av en gastronintestinalt verksam kompostion
US5807572A (en) * 1988-02-18 1998-09-15 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
FR2649610B1 (fr) * 1989-07-13 1994-06-03 Dior Christian Parfums Composition cosmetique ou pharmaceutique et notamment dermatologique contenant de l'ampc ou ses derives en liposomes
DE4005711C1 (fr) * 1990-02-23 1991-06-13 A. Nattermann & Cie Gmbh, 5000 Koeln, De
DE4108903A1 (de) * 1990-08-06 1992-02-13 Nattermann A & Cie Pharmazeutisches produkt
US5556637A (en) * 1990-08-06 1996-09-17 A. Nattermann & Cie. Gmbh Water containing liposome system
DE4107153A1 (de) * 1991-03-06 1992-09-10 Gregor Cevc Praeparat zur wirkstoffapplikation in kleinsttroepfchenform
DE4107152C2 (de) * 1991-03-06 1994-03-24 Gregor Cevc Präparate zur nichtinvasiven Verabreichung von Antidiabetica
US6165500A (en) * 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
FR2685868B1 (fr) * 1992-01-03 1995-06-23 Corbiere Jerome Nouvelles preparations pharmaceutiques a base de peptides pour la voie generale.
WO1995001163A1 (fr) * 1992-01-03 1995-01-12 Corbiere Jerome Nouvelles preparations pharmaceutiques a base de peptides pour la voie generale
WO1993013751A1 (fr) * 1992-01-16 1993-07-22 Board Of Regents, The University Of Texas System Formulation a base de carotenoides et utilisation de ces derniers dans le traitement du cancer
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
US5989587A (en) * 1992-10-23 1999-11-23 National Research Council Of Canada Formation of stable liposomes from lipid extracts of archaeobacteria (archaeu)
JPH0657741U (ja) * 1993-01-22 1994-08-12 株式会社村上開明堂 監視機能付きミラー装置
US5455044A (en) * 1993-05-14 1995-10-03 Depotech Corporation Method for treating neurological disorders
US5853755A (en) * 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
IL107471A (en) * 1993-11-02 1997-09-30 Yissum Res Dev Co Pharmaceutical preparation comprising a self- emulsifying formulation and process for its production
JP3002702B2 (ja) * 1993-11-16 2000-01-24 スカイファーム インコーポレーテッド 活性物質の制御放出を有する小胞
US5840328A (en) * 1994-01-11 1998-11-24 The Liposome Company, Inc. Treatment using arachidonic acid metabolite and particulate formulations
AU3361595A (en) * 1994-08-08 1996-03-07 Argus Pharmaceuticals, Inc. Formulation and use of carotenoids in treatment of cancer
US5993850A (en) * 1994-09-13 1999-11-30 Skyepharma Inc. Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
AU692255B2 (en) * 1995-04-24 1998-06-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
US5931809A (en) 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
US5997899A (en) 1996-10-01 1999-12-07 Skyepharma Inc. Method for producing liposomes with increased percent of compound encapsulated
WO1999002139A1 (fr) * 1997-07-10 1999-01-21 Keith Baker Procedes permettant d'alimenter le cerveau en agents therapeutiques de façon universelle
US6306432B1 (en) 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
ES2343767T3 (es) 1997-09-18 2010-08-09 Pacira Pharmaceuticals, Inc. Composiciones anestesicas liposomicas de liberacion sostenida.
JP4575592B2 (ja) 1997-11-14 2010-11-04 パシラ ファーマシューティカルズ インコーポレーテッド 多小胞リポソームの製造
CN1320880C (zh) 1998-12-23 2007-06-13 伊迪亚股份公司 改进的体内局部无创伤用制剂
PT1031347E (pt) 1999-01-27 2002-09-30 Idea Ag Transporte/imunizacao transnasal com veiculos muitissimo adaptaveis
EP1031346B1 (fr) 1999-01-27 2002-05-02 Idea Ag Vaccination non invasive à travers la peau
MXPA02000053A (es) 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
US20030068361A1 (en) * 2001-10-09 2003-04-10 Rimona Margalit Liposome-encapsulated insulin formulations
US20040105881A1 (en) 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
WO2011162818A2 (fr) * 2010-06-23 2011-12-29 Controlled Nanovolumes, Inc. Vésicules porteuses de lécithine et leurs procédés de fabrication
US20200107999A1 (en) * 2017-05-23 2020-04-09 Tci Co., Ltd Emulsified liposome composition and preparation process thereof
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
GB2627096A (en) 2021-10-14 2024-08-14 Pacira Pharmaceuticals Inc Bupivacaine multivesicular liposome formulations and uses thereof
US12246092B1 (en) 2024-05-20 2025-03-11 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251468B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49118826A (fr) * 1971-10-12 1974-11-13
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
JPS5513260A (en) * 1978-04-14 1980-01-30 Little Inc A Xenobiotics transfer vehicles*their production and use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3060030A (en) * 1960-04-04 1962-10-23 Carl F Obenauf Lecithinated product
JPS5126213A (ja) * 1974-08-21 1976-03-04 Tanabe Seiyaku Co Johoseibiryushiseizaino seiho
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49118826A (fr) * 1971-10-12 1974-11-13
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
JPS5513260A (en) * 1978-04-14 1980-01-30 Little Inc A Xenobiotics transfer vehicles*their production and use

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60152410A (ja) * 1984-01-23 1985-08-10 Pola Chem Ind Inc 皮膚外用剤
JPS60243022A (ja) * 1984-04-09 1985-12-03 サンド・アクチエンゲゼルシヤフト インタ−リユ−キン療法に関する改良
JPS61100518A (ja) * 1984-10-22 1986-05-19 Ono Pharmaceut Co Ltd ジミリストイルホスフアチジルコリンを主成分とする凍結乾燥されたリポゾ−ム製剤
WO2005053643A1 (fr) * 2003-12-01 2005-06-16 Mitsubishi Pharma Corporation Liposome
JP2015514683A (ja) * 2012-02-16 2015-05-21 ブライトサイド イノベーションズ，インコーポレイティド 食品性栄養組成物および使用方法
US10888572B2 (en) 2012-02-16 2021-01-12 Bio-Up Mimetic Technologies, Inc. Dietary and nutritional compositions and methods of use
JP2017066059A (ja) * 2015-09-28 2017-04-06 小林製薬株式会社 リポソーム
WO2017057418A1 (fr) * 2015-09-28 2017-04-06 小林製薬株式会社 Liposome

Also Published As

Publication number Publication date
CA1143656A (fr) 1983-03-29
GB2050287B (en) 1983-04-20
DE3016976A1 (de) 1980-11-13
FR2455458A1 (fr) 1980-11-28
FR2455458B1 (fr) 1983-04-15
JPH0240644B2 (fr) 1990-09-12
GB2050287A (en) 1981-01-07

Similar Documents

Publication Publication Date Title
FR2455458A1 (fr) Liposomes contenant une substance active, notamment un principe actif de medicament
DE3172223D1 (en) Edible, pharmaceutical compositions and processes for making thereof
EP0098566A3 (en) Corticoids-containing preparation for topical application
AU567271B2 (en) Lyophilization of oil in water emulsion to give galenic form for oral administration
NO171443C (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende syntetiske lipider
ATE74513T1 (de) Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen.
DK1053011T3 (da) System i form af blandede miceller til indgivelse af lægemiddelstoffer og fremgangsmåde til fremstilling heraf
KR840005339A (ko) 지용성물질을 함유한 수용액의 제조방법
KR900701174A (ko) 인지질-함유 조성물, 이의 제조방법 및 이의 약제학적 물질용 부형제로서의 용도
KR830005854A (ko) 알카리성 진통제 캡슐의 제조방법
DE69227580T2 (de) Wasser-in-öl-emulsionen, die lipidvesikel enthalten
JPS5517328A (en) Insulin-containing emulsion and its preparation
JPS56127308A (en) Blood-coagulation factor 8 pharmaceutical
KR890701098A (ko) 히드로퀴논 및 코지산을 함유하는 제약 또는 화장제 조성물
BE877658A (fr) Nouveaux derives acetyleniques de l'androst-4-ene, leur procede de preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
FR2368490A1 (fr) Nouveaux derives de l'acide clavulanique, leur preparation et compositions pharmaceutiques en contenant
SE9402455D0 (sv) Bilayer preparations
BE881625A (fr) Esters o-alcoxycarbonyl-phenyliques d'un acide anthranilique leur preparation et compositions pharmaceutiques en contenant
JPS56166108A (en) Base for cosmetic and medicine
DE3266072D1 (en) Method for the oral administration of substances in the form of liposomes, and relative pharmaceutical compositions
JPS57149219A (en) Hard capsule preparation containing tocopherol nicotinate in high concentration
JPS57109713A (en) Pharmaceutical preparation of combined agent of sulfamethoxazole and trimethoprim for medication through celom
JPS55105623A (en) Preparation of filler for hard capsules
JPS5762220A (en) Embrocation for external use
JPS5695143A (en) 4-substituted nonanal and its preparation